• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Effects of a high-fat meal on the relative oral bioavailability of piperaquine.高脂餐对哌喹相对口服生物利用度的影响。
Antimicrob Agents Chemother. 2005 Jun;49(6):2407-11. doi: 10.1128/AAC.49.6.2407-2411.2005.
2
Pharmacokinetics of the antimalarial drug piperaquine in healthy Vietnamese subjects.抗疟药物哌喹在健康越南受试者中的药代动力学。
Am J Trop Med Hyg. 2008 Oct;79(4):620-3.
3
Effects of food intake on the pharmacokinetic properties of dalcetrapib: findings from three phase I, single-dose crossover studies in healthy volunteers.饮食对 dalcetrapib 药代动力学特性的影响:来自健康志愿者的三项 I 期、单次交叉研究的结果。
Clin Ther. 2011 Jun;33(6):754-65. doi: 10.1016/j.clinthera.2011.05.046.
4
The effect of food on the absorption of oral ziprasidone.食物对口服齐拉西酮吸收的影响。
Psychopharmacol Bull. 2007;40(3):58-68.
5
Relative bioavailability of sapropterin from intact and dissolved sapropterin dihydrochloride tablets and the effects of food: a randomized, open-label, crossover study in healthy adults.盐酸沙丙蝶呤片完整片和溶解片的相对生物利用度及食物的影响:一项在健康成年人中开展的随机、开放标签、交叉研究。
Clin Ther. 2010 Feb;32(2):338-46. doi: 10.1016/j.clinthera.2010.02.012.
6
The effect of a high-fat meal on the oral bioavailability of the immunosuppressant sirolimus (rapamycin).高脂餐对免疫抑制剂西罗莫司(雷帕霉素)口服生物利用度的影响。
J Clin Pharmacol. 1999 Nov;39(11):1155-61.
7
Evaluation of the effects of formulation and food on the pharmacokinetics of lenvatinib (E7080) in healthy volunteers.评估制剂和食物对健康志愿者中乐伐替尼(E7080)药代动力学的影响。
Int J Clin Pharmacol Ther. 2014 Apr;52(4):284-91. doi: 10.5414/CP201937.
8
A new fenofibrate formulation: results of six single-dose, clinical studies of bioavailability under fed and fasting conditions.一种新的非诺贝特制剂:六项单剂量临床研究在进食和空腹条件下的生物利用度结果。
Clin Ther. 2004 Sep;26(9):1456-69. doi: 10.1016/j.clinthera.2004.09.015.
9
Effect of food on the pharmacokinetics of piperaquine and dihydroartemisinin.食物对哌喹和双氢青蒿素药代动力学的影响。
Clin Drug Investig. 2015 Sep;35(9):559-67. doi: 10.1007/s40261-015-0312-8.
10
Bioavailability of a co-formulated combination of amodiaquine and artesunate under fed and fasted conditions. A randomised, open-label crossover study.阿莫地喹与青蒿琥酯复方制剂在进食和空腹条件下的生物利用度:一项随机、开放标签交叉研究。
Arzneimittelforschung. 2009;59(7):370-6. doi: 10.1055/s-0031-1296410.

引用本文的文献

1
Pharmacokinetics of a Novel Piperaquine Dispersible Granules Formulation Under Fasting and Various Fed Conditions Versus Piperaquine Tablets When Fasted in Healthy Tanzanian Adults: A Randomized, Phase I Study.新型磷酸哌喹分散片剂在坦桑尼亚健康成年受试者空腹及不同进食条件下与空腹服用磷酸哌喹片相比的药代动力学:一项随机I期研究
Clin Transl Sci. 2025 Feb;18(2):e70133. doi: 10.1111/cts.70133.
2
Drug resistance of Plasmodium falciparum and Plasmodium vivax isolates in Indonesia.印度尼西亚地区间恶性疟原虫和间日疟原虫分离株的耐药性。
Malar J. 2022 Nov 28;21(1):354. doi: 10.1186/s12936-022-04385-2.
3
Electrocardiographic effect of artemisinin-piperaquine, dihydroartemisinin-piperaquine, and artemether-lumefantrine treatment in falciparum malaria patients.青蒿琥酯-哌喹、双氢青蒿素-哌喹和青蒿琥酯-咯萘啶治疗恶性疟原虫疟疾患者的心电图效应。
Rev Soc Bras Med Trop. 2021 Feb 10;54:e05362020. doi: 10.1590/0037-8682-0536-2020. eCollection 2021.
4
Combining antimalarial drugs and vaccine for malaria elimination campaigns: a randomized safety and immunogenicity trial of RTS,S/AS01 administered with dihydroartemisinin, piperaquine, and primaquine in healthy Thai adult volunteers.联合抗疟药物和疫苗进行疟疾消除运动:在健康泰国成年志愿者中使用双氢青蒿素、哌喹和伯氨喹联合 RTS,S/AS01 进行的随机安全性和免疫原性试验。
Hum Vaccin Immunother. 2020;16(1):33-41. doi: 10.1080/21645515.2019.1643675. Epub 2019 Aug 15.
5
Optimal dosing of dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in young children.小儿季节性疟疾化学预防中双氢青蒿素-哌喹的最佳剂量。
Nat Commun. 2019 Jan 29;10(1):480. doi: 10.1038/s41467-019-08297-9.
6
Effects of Dihydroartemisinin-Piperaquine Phosphate and Artemether-Lumefantrine on QTc Interval Prolongation.双氢青蒿素哌喹磷酸酯和青蒿琥酯-咯萘啶对 QTc 间期延长的影响。
Sci Rep. 2019 Jan 28;9(1):777. doi: 10.1038/s41598-018-37112-6.
7
Identification of beagle food taking patterns and protocol for food effects evaluation on bioavailability.鉴定比格犬的摄食模式和用于评估生物利用度的食物效应方案。
Sci Rep. 2018 Aug 24;8(1):12765. doi: 10.1038/s41598-018-30937-1.
8
Risk of sudden unexplained death after use of dihydroartemisinin-piperaquine for malaria: a systematic review and Bayesian meta-analysis.使用双氢青蒿素哌喹治疗疟疾后突发原因不明死亡的风险:系统评价和贝叶斯荟萃分析。
Lancet Infect Dis. 2018 Aug;18(8):913-923. doi: 10.1016/S1473-3099(18)30297-4. Epub 2018 Jun 18.
9
Comparison of the Pharmacokinetics and Ex Vivo Antimalarial Activities of Artesunate-Amodiaquine and Artemisinin-Piperaquine in Healthy Volunteers for Preselection Malaria Therapy.比较青蒿琥酯-阿莫地喹和青蒿素-哌喹在健康志愿者中的药代动力学和抗疟体外活性,用于疟疾治疗的初步选择。
Am J Trop Med Hyg. 2018 Jul;99(1):65-72. doi: 10.4269/ajtmh.17-0434. Epub 2018 May 3.
10
Piperaquine Population Pharmacokinetics and Cardiac Safety in Cambodia.柬埔寨的哌喹群体药代动力学与心脏安全性
Antimicrob Agents Chemother. 2017 Apr 24;61(5). doi: 10.1128/AAC.02000-16. Print 2017 May.

本文引用的文献

1
Piperaquine: a resurgent antimalarial drug.哌喹:一种重新兴起的抗疟药物。
Drugs. 2005;65(1):75-87. doi: 10.2165/00003495-200565010-00004.
2
Population pharmacokinetics of piperaquine in adults and children with uncomplicated falciparum or vivax malaria.磷酸哌喹在非复杂性恶性疟或间日疟成人及儿童中的群体药代动力学。
Br J Clin Pharmacol. 2004 Mar;57(3):253-62. doi: 10.1046/j.1365-2125.2003.02004.x.
3
Dihydroartemisinin-piperaquine against multidrug-resistant Plasmodium falciparum malaria in Vietnam: randomised clinical trial.双氢青蒿素-哌喹治疗越南耐多药恶性疟原虫疟疾:随机临床试验
Lancet. 2004 Jan 3;363(9402):18-22. doi: 10.1016/s0140-6736(03)15163-x.
4
A standardized triglyceride and carbohydrate challenge: the oral triglyceride tolerance test.标准化甘油三酯和碳水化合物激发试验:口服甘油三酯耐量试验
Diabetes Care. 2004 Jan;27(1):89-94. doi: 10.2337/diacare.27.1.89.
5
Measurement of piperaquine in plasma by liquid chromatography with ultraviolet absorbance detection.采用液相色谱-紫外吸收检测法测定血浆中的哌喹。
J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Jul 5;791(1-2):93-101. doi: 10.1016/s1570-0232(03)00209-5.
6
Safety and therapeutic efficacy of artesunate suppositories for treatment of malaria in children in Papua New Guinea.青蒿琥酯栓剂治疗巴布亚新几内亚儿童疟疾的安全性和疗效
Pediatr Infect Dis J. 2003 Mar;22(3):251-6. doi: 10.1097/01.inf.0000054826.80221.75.
7
Food-drug interactions.食物-药物相互作用
Drugs. 2002;62(10):1481-502. doi: 10.2165/00003495-200262100-00005.
8
Food increases the bioavailability of mefloquine.食物可提高甲氟喹的生物利用度。
Eur J Clin Pharmacol. 1997;53(2):135-9. doi: 10.1007/s002280050351.
9
Antimalarial drugs and glucose metabolism.抗疟药物与葡萄糖代谢。
Br J Clin Pharmacol. 1997 Jul;44(1):1-7. doi: 10.1046/j.1365-2125.1997.00597.x.
10
[Randomised comparison on the treatment of falciparum malaria with dihydroartemisinin and piperaquine].双氢青蒿素与哌喹治疗恶性疟的随机对照研究
Zhonghua Yi Xue Za Zhi. 1993 Oct;73(10):602-4, 638.

高脂餐对哌喹相对口服生物利用度的影响。

Effects of a high-fat meal on the relative oral bioavailability of piperaquine.

作者信息

Sim Ing-Kye, Davis Timothy M E, Ilett Kenneth F

机构信息

Medicine Unit Fremantle, M510, School of Medicine and Pharmacology, University of Western Australia, Crawley 6009, Australia.

出版信息

Antimicrob Agents Chemother. 2005 Jun;49(6):2407-11. doi: 10.1128/AAC.49.6.2407-2411.2005.

DOI:10.1128/AAC.49.6.2407-2411.2005
PMID:15917540
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1140540/
Abstract

Piperaquine (PQ) is an antimalarial drug whose high lipid solubility suggests that its absorption can be increased by a high-fat meal. We examined the pharmacokinetics of PQ phosphate (500 mg given orally) in the fasting state and after a high-fat meal in eight healthy Caucasian volunteers (randomized crossover). Plasma PQ concentration-time profiles were analyzed by using noncompartmental pharmacokinetic analysis. In the fed state, the geometric mean Cmax increased by 213%, from 21.0 to 65.8 microg/liter (P<0.001). The time of Cmax was not significantly different between the fasting and fed states. The geometric mean area under the concentration-time curve from zero onward (AUC0-infinity) increased by 98%, from 3,724 to 7,362 microg h/liter (P=0.006). The oral bioavailability of PQ relative to the fasting state was 121% greater after the high-fat meal (95% confidence interval, 26 to 216% increase; P=0.020). The side effects, postural blood pressure changes, electrocardiographic corrected QT interval, serum glucose, and other biochemical and hematological indices were similar in the fasting and fed states over 28 days of follow-up.

摘要

哌喹(PQ)是一种抗疟药物,其高脂溶性表明高脂餐可增加其吸收。我们在8名健康的白种志愿者中(随机交叉)研究了空腹状态下和高脂餐后口服磷酸哌喹(500毫克)的药代动力学。采用非房室药代动力学分析方法分析血浆哌喹浓度-时间曲线。在进食状态下,几何平均Cmax增加了213%,从21.0微克/升增至65.8微克/升(P<0.001)。空腹和进食状态下Cmax出现的时间无显著差异。从0时起浓度-时间曲线下的几何平均面积(AUC0-∞)增加了98%,从3724微克·小时/升增至7362微克·小时/升(P=0.006)。高脂餐后哌喹相对于空腹状态的口服生物利用度提高了121%(95%置信区间,增加26%至本信息由辽宁省朝阳市中心医院药剂科副主任药师赵志刚提供。216%;P=0.020)。在28天的随访中,空腹和进食状态下的副作用、体位性血压变化、心电图校正QT间期、血糖以及其他生化和血液学指标相似。